Last reviewed · How we verify
NCT04597645
Prader-Willi Syndrome Body Composition
NA trial testing Therapeutic elastic band resistance training in Prader Labhart Willi Syndrome in 20 participants. Completed in 31 July 2021.
31 July 2021
Quick facts
| Lead sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 6 May 2020 |
| Primary completion | 31 July 2021 |
| Estimated completion | 31 July 2021 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Therapeutic elastic band resistance training
Conditions studied
- Prader Labhart Willi Syndrome — all drugs for Prader Labhart Willi Syndrome →
- Body Weight Changes — all drugs for Body Weight Changes →
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Who can join
Adults 18 to 65, any sex, with Prader Labhart Willi Syndrome or Body Weight Changes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adults aged over 18 years, with the diagnosis of Prader-willi syndrome will be recruited through the hospital's outpatient clinic for either as intervention group receiving therapeutic elastic band training, or as control group receiving usual care for a total of 16 weeks. Body composition, physical capacity, and serum changes will be assessed before and after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04597645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation trials
Trials by the same sponsor.
- NCT07357142 — Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome · NA · not yet recruiting
- NCT07310797 — Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion · Phase 4 · not yet recruiting
- NCT07472803 — Longitudinal Body Composition Assessment in Breast Cancer Patients · recruiting
- NCT07151963 — Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy · NA · enrolling by invitation
- NCT06428942 — Low-potassium Content Vegetables in Chronic Kidney Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04597645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Last refreshed: 3 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing